We are looking for young people 2–17 years of age to join a Crohn’s disease research to help us discover more about treating Crohn’s and UC. If you are looking for a potential new treatment option for Crohn’s and UC or moderate to severe IBD (including associated symptoms such as abdominal cramps, reduced appetite, diarrhea, chronic fatigue and/or anemia), consider one of our GI research studies. All eligible participants will receive no-cost study-related care and study medication. Your child or teen 2–17 years of age may be eligible to take part.

Your child may be eligible to take part in the GI research studies if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Find out if your child may be able to to join.

Is your child currently experiencing gastrointestinal disease flare-ups? Local CD study is testing a potential new medication to see if it may reduce swollen joints, weight loss, diarrhea, chronic fatigue, and/or eye pain associated with gastrointestinal disease.
If you’re concerned about how gastrointestinal disease affects your child’s life, find out more about the CD study.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Enrollment is limited, so please respond now.

We are looking for children at least 2 years of age but under 18 to join a research to help us discover more about treating Crohn’s disease (CD). If you are looking for a potential new treatment option for Crohn’s disease (CD) or IBD (including associated symptoms such as chronic diarrhea, failure to thrive, bloody stool, frequent fevers and/or joint pain), consider one of our Crohn’s disease (CD) research. All eligible participants will receive no-cost study-related care and study medication. Your children at least 2 years of age but under 18 may be eligible to take part.

Your child may be eligible to take part in the Crohn’s disease (CD) research if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Enrollment is limited, so please respond now.

Is your child currently experiencing inflammatory bowel disease flare-ups? Local research is testing a potential new medication to see if it may reduce cramps, loss of appetite, constant need to poop, chronic fatigue, and/or anemia associated with inflammatory bowel disease.
If you’re concerned about how inflammatory bowel disease affects your child’s life, find out more about the research.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Act now.

We are looking for young people 2–17 years old to join a Crohn’s disease clinical trial to help us discover more about treating Crohn’s and ulcerative colitis. If you are looking for a potential new treatment option for Crohn’s and ulcerative colitis or ulcerative colitis (including associated symptoms such as rectal bleeding, failure to thrive, bloody stool, weight loss and/or liver disease), consider one of our clinical research. All eligible participants will receive no-cost study-related care and study medication. Your young people 2–17 years old may be eligible to take part.

Your child may be eligible to take part in the clinical research if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Act now.

Is your child currently experiencing moderate to severe IBD flare-ups? Local Crohn’s disease study is testing a potential new medication to see if it may reduce abdominal cramping, reduced appetite, abdominal pain, malnutrition, and/or liver disease associated with moderate to severe IBD.
If you’re concerned about how moderate to severe IBD affects your child’s life, find out more about the Crohn’s disease study.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Enrollment is limited so act quickly.

We are looking for children and teenagers 2–17 years of age to join a research to help us discover more about treating CD. If you are looking for a potential new treatment option for CD or CD and UC (including associated symptoms such as fatigue, iron deficiency, cramps, chronic fatigue and/or anemia), consider one of our clinical trials. All eligible participants will receive no-cost study-related care and study medication. Your children and teenagers 2–17 years of age may be eligible to take part.

Your child may be eligible to take part in the clinical trials if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Enrollment is limited so act quickly.

Is your child currently experiencing IBD flare-ups? Local Crohn’s disease (CD) research is testing a potential new medication to see if it may reduce fatigue, growth failure, cramps, malnutrition, and/or liver disease associated with IBD.
If you’re concerned about how IBD affects your child’s life, find out more about the Crohn’s disease (CD) research.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Enrollment is limited, so please respond now.

We are looking for 2–17 year olds to join a Crohn’s disease (CD) medical research study to help us discover more about treating ulcerative colitis. If you are looking for a potential new treatment option for ulcerative colitis or UC (including associated symptoms such as urgency to defecate, fistula, constant need to poop, frequent fevers and/or eye pain), consider one of our UC studies. All eligible participants will receive no-cost study-related care and study medication. Your 2–17 years old may be eligible to take part.

Your child may be eligible to take part in the UC studies if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Enrollment is limited, so please respond now.

Is your child currently experiencing ulcerative colitis flare-ups? Local Crohn’s disease (CD) medical research study is testing a potential new medication to see if it may reduce chronic diarrhea, loss of appetite, constant need to poop, frequent fevers, and/or liver disease associated with ulcerative colitis.
If you’re concerned about how ulcerative colitis affects your child’s life, find out more about the Crohn’s disease (CD) medical research study.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Enrolling for a limited time.